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1. Introduction 
Aging and death are two natural consequences to which the human individuals are subject 
after their birth. Improvement in both social living conditions and health care has led to a 
greater life span in the world 1, resulting in an increase in periodontal disease expectancy 
among the dentate elderly 2. Although moderate loss of both alveolar bone and periodontal 
attachment is common in the elderly, severe periodontitis, defined as periodontal 
attachment loss of 6 mm or more and radiographic bone loss of 50% or more involving at 
least one tooth, is not a natural consequence of ageing. Some loss of periodontal attachment 
and alveolar bone may be expected in older persons, but age alone in healthy adults does 
not lead to a critical loss of periodontal support 3. 
Human ageing induces histophysiological and clinical alterations in oral tissues 4. These 
alterations must be understood to differentiate pathological conditions from the altered 
physiology of oral tissues resulting from ageing 5. Some studies in humans and animals 
have demonstrated that alterations in periodontium dynamics occur with age 6,7.  
In spite of the fact that the periodontal disease severity is known to be associated with age, 
functional changes in periodontal tissue cells during the ageing process have not been well 
characterized 8. It is important to define how cellular ageing affects the progression of 
periodontal diseases associated with ageing 6. The understanding of the influence of human 
aging in the dynamic of the inflammatory process in patients with periodontal disease may 
help in the treatment planning of these patients. 
2. Age-dependent changes of the periodontal tissues 
The tissues that support the teeth are called the periodontium, which consists of gingiva, 
periodontal ligament, cementum, and alveolar bone. Anatomical and functional changes in 
periodontal tissues have been reported as being associated with the ageing process 9.  
Gingiva, a tissue exposed to the oral cavity, is histologically composed by epithelium and 
connective tissues. Changes in the human oral epithelium caused by ageing are related to a 
thinning of the epithelium and diminished keratinization. Conflicting results have been 
reported regarding the shape of the retepegs. A flattening of retepegs and an increase in the 
height of the epithelial ridges associated with ageing were both demonstrated. In a 
morphological 3-dimensional study of the epithelium-connective tissue interface, connective 
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tissue ridges were observed to be more prevalent in young individuals whereas connective 
tissue papillae were predominant in old individuals. The change from ridges to papillae 
involves the formation of epithelial cross-ridges with advanced age 9.  
Furthermore, it has been shown that the number of cellular elements decreases as age 
increases. The fibroblasts are the main cells in the synthesis of periodontal connective tissue. 
There are phenotypic subpopulations of fibroblasts with different functions in the synthesis 
and maintenance of extracellular matrix constituents 10. In vivo and in vitro studies have 
shown functional and structural alterations in fibroblasts associated with ageing 6, 11-13.  
Gingival fibroblasts (GF) may be constantly affected by oral bacteria and their products, 
such as the lipopolysaccharides (LPS), present in their cell walls. The LPS induces GF to 
release some inflammatory cytokines such as prostaglandin E2 (PGE2), interleukin (IL)-1 ┚, 
and plasminogen activator (PA) 6, 14. The influence of these inflammatory mediators on both 
GF and periodontal ligament fibroblasts (PLF) might account for the severity of periodontal 
disease 6.  
Quantitative differences in protein synthesis were found in young and old gingival 
fibroblasts in vitro. The collagen production decreased more than 5-fold as a function of 
increasing donor age 15. Old fibroblasts also presented an increased rate of collagen 
intracellular phagocytosis, which can affect the balance between synthesis and degradation 
of collagen in the connective tissue 12. The ageing process in GF causes an increase in DNA 
structure metilation of collagen alpha 1 gene, followed by a reduction in mRNA levels and 
collagen type I synthesis 13. Alterations in the composition of extracellular matrix 
proteoglycans secreted by GF in vitro were also observed. The proteoglycans secreted by old 
fibroblasts might increase the rates of heparan sulfate and reduce chondroitin sulfate when 
compared to those secreted by young fibroblasts 16.  
The periodontal ligament, which is a soft connective tissue, anchors the tooth into the 
alveolar bone and functions as a cushion between hard tissues to mitigate the occlusal force. 
It is basically constituted by fibroblasts, cementoblasts, osteoblasts, osteoclasts, Malassez 
epithelial rests and collagen matrix (Sharpey´s fibers). The periodontal ligament cells are 
involved in the repair of alveolar bone, cementum and periodontal ligament itself, being 
able to differentiate into osteblasts, cementoblasts and fibroblasts 17. With age, the fiber and 
cellular contents decrease and the structure of the periodontal ligament becomes irregular. 
Periodontal ligament fibroblasts (PLF) are constantly subject to mechanical stress caused by 
occlusal forces. Cultured PLF were observed to produce a large amount of PGE2, IL-1┚, and 
PA in response to mechanical stress 6. 
The ageing process might induce a significant reduction in chemotaxy, motility, and 
proliferation rate of periodontal ligament cells. The chemotaxy and differentiation of 
osteoclasts from the periodontal ligament induced by devitalized osseous matrix might be 
influenced by donor’s age. A reduction in osteoblast chemotaxy and lower rate of osteoclast 
differentiation in the cells of elderly donors were observed 18.  
The cells of the periodontal ligament from the elderly showed lower rates of chemotaxy and 
proliferation than those of the periodontal ligament from young patients 19. The reduced 
ability of senescent cells to express the c-fos ligant might be associated with the low rates of 
chemotaxy and proliferation of these cells 20. The expression of osteocalcin in fibroblasts 
from the periodontal ligament is either reduced or ceased in senescent fibroblasts. This 
reduction may be directly related to the cell’s difficulty in progressing in the cellular cycle 
(G1-S) and accomplishing cell respiration 21. 
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Cementum is a calcified connective tissue covering the roots of teeth. Its formation is a 
continuous process which occurs throughout the life of humans and animals. With age, the 
cementum increases in width. It has been demonstrated that there is a tendency towards 
greater cemental apposition in the apical region of the teeth. Collagen fibers are embedded 
in the cementum during its formation 9. Ageing and death of cells are common 
characteristics of the life cycle of the cementocytes. This might be due to a rapid reduction in 
the accessibility of nutritive substances and poor elimination of waste products of the 
cementocytes. In general, cementum is cellular except at the root apices and in the furcation 
areas of multirooted teeth. With age, cementum becomes acellular. Although remodeling of 
cementum occurs infrequently, resorption at the cementum surface followed by cementum 
apposition is often observed and, with age, this might result in irregular cementum surfaces 
9, 22.  
Both the alveolar bone and the periodontal ligament serve as support to the teeth. It is well 
known that bone formation steadily declines with age, leading to a significant reduction in 
bone mass 23. The alveolar bone has high plasticity and under physiological conditions it is 
preserved by the equilibrium between osteoblastic and osteoclastic activities. These cells are 
directly or indirectly influenced by the parathyroid hormone (PTH), vitamin D metabolites, 
calcitonin, estrogen, plasmatic concentration of calcium and phosphate, neurotransmitters, 
growth factors, and local cytokines 24.  
The reduction in bone formation might be due to a decrease in osteoblast-proliferating 
precursors or to decreased synthesis and secretion of essential bone matrix proteins 6, 23. The 
extracellular matrix surrounding osteoblasts has been shown to play an important role in 
bone metabolism. A possible dysfunction of this matrix might occur concomitantly with the 
ageing process 6. 
Oxygen-free radicals have been reported to cause cellular damage and, consequently, 
contribute to the ageing process 25, 26. In an in vitro study, oxygen radical-treated fibronectin 
(FN) was found to inhibit bone nodule formation by osteoblasts when compared to intact 
FN. This finding suggested that intact FN plays an important role in osteoblast activity and 
that FN damaged by oxygen radicals during the ageing process might be related to less bone 
formation 6. 
3. Systemic ageing and periodontium 
Some alterations in the organism endocrine profile influence the osseous metabolism with 
age. Vitamin D deficiency is a common phenomenon in persons living in elderly homes 27. 
The low levels of calcium resulting from vitamin D deficiency associated with renal 
insufficiency might lead to secondary hyperparathyroidism 28. The high levels of PTH 
resulting from secondary hyperparathyroidism act in the mobilization of osseous calcium, 
which might cause mineralization problems, bone fractures, and a reduction in osseous 
density 29. With regard to the periodontium, osteopenia and osteoporosis are considered 
important risk factors for alveolar bone loss in the presence of periodontal diseases 30, 31.  
Female patients with osteoporosis or osteopenia presented greater levels of alveolar bone 
loss, when compared to patients with normal mineral osseous density 32, 33. Estrogen hormonal 
reposition therapy in patients with osteoporosis might reduce gingival inflammation and 
alveolar bone loss in relation to patients with untreated osteoporosis 34, 35. In a randomized 
double-blind study, patients with osteoporosis treated with estrogen reposition showed an 
increase in alveolar bone levels, when compared to the placebo group 36.  
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The supplement ingestion of calcium (1000-1200 mg/day) and vitamin D (400-600 IU/day) 
in elderly patients with osteoporosis has been tested. After 5 years of treatment, the results 
showed a reduction in tooth loss in patients who ingested calcium and vitamin D, when 
compared to the placebo group 37. Studies evaluating periodontal status and hormonal 
reposition therapies, indicated for prevention and treatment of osteoporosis, have reported 
the reduction in alveolar bone loss and tooth loss as secondary benefits. It is worth 
emphasizing that some risks in hormonal reposition therapy have been recently reported; 
for example, an increase in the incidence of breast cancer, thromboembolic diseases, and 
myocardial infarction has been found 38.  
4. Immunosenescence and periodontal cells interaction 
Immunosenescence refers to the gradual deterioration of the immune system caused by 
natural aging. It involves the host’s capacity to respond to infections and the development of 
long-term immune memory. This is not a random deteriorative phenomenon; rather it 
appears to repeat inversely an evolutionary pattern. Most of the parameters affected by 
immunosenescence appear to be under genetic control. Immunosenescence can also be 
sometimes envisaged as the result of the continuous challenge of the unavoidable exposure 
of the organism to a variety of antigens such as viruses and bacteria 39.  
Aging is a complex, continuous, and slow process that gradually involves most if not all 
organs of the organism, causing their abnormal functioning of in both qualitative and 
quantitative terms, as well as morphological or structural changes. So, senescence is not 
represented by a pre-established moment, but consists of a long-lasting preparation of the 
organism for a morpho-functional involution, which itself is a normal part of the biological 
cycle 40. In this context, periodontal tissues also are included. 
The immune system also undergoes age-related modifications leading to structural changes 
in the lymphoid organs, and functional impairment of some types of immunocompetent 
cells. The most evident changes in the immune system occur in the thymus, a specialized 
organ of the immune system. The thymus is a primary lymphoid organ, but also an 
endocrine gland, responsible for T-cell production and maturation 41.  
The thymus is the largest and most active during the neonatal and pre-adolescent periods. 
By the early teens, the thymus begins to atrophy and thymic stroma is replaced by adipose 
tissue. Nevertheless, residual T lymphopoiesis continues throughout adult life. Thymus 
involution in humans is observed until the age of 70 years 42. The consequences of thymic 
involution in the peripheral pool of T-cells are still a matter of controversy. Thus, whereas 
some authors report no significant decline in the total number of T-cells, but considerable 
shifts in the ratios of activated/memory T-cells 41, others claim that the age-related changes 
in the thymus and T-cells are quantitative, not qualitative 43. In any case, it remains to be 
clarified whether changes in the immune system with age have something to do with 
survival 44, although the stage of being elderly is associated with an increase in infections, 
tumors, and other diseases related to a decline in the immune function 45.  
T-lymphocytes are considered thymus-dependent cells of fundamental importance in the 
immune response. Reductions in peripheral blood T-lymphocytes, mitotic agents, anti-CD3, 
and monoclonal antibodies are the main alterations in the senescent phenotypes of T-
lymphocytes. The proliferative phase alterations in T-lymphocytes may be induced by the 
reduced secretion of interleukin-2 (IL-2) and reduced expression of its high-affinity 
receptors. The reduced expression patterns of IL-2 and IL-2R in peripheral monocytes of 
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elderly patients have been reported as influencing the proliferative response of T-
lymphocytes 46. IL-2 is produced by helper T-cells and plays an important role in the 
proliferation and differentiation of virgin T-cells into effector T-cells (this term is used 
frequently for populations of T-cells with cytolytic activities and for T-helper cells, which 
secrete cytokines and activate directly other immune cells, to distinguish them from another 
class of T-cells known as regulatory T-cells) 47.  
Ageing-related immunological alterations in the leukocyte subpopulations 48 and B-
lymphocyte subpopulations 49 have been reported. The reduction in the peripheral blood 
population of B-lymphocytes is associated with the decrease in the production of high-
specificity antibodies as well as in the avidity of antigen-antibody legation 50. In 
establishment of long-term memory of immune response, the maturation of antigen-induced 
CD4+ T-cells, which are postthymic human cell, results in the terminally differentiated 
CD45RA+. An increase in CD45RA+ memory cell circulation in relation to CD45RO+ virgin 
cells disturbing the response to new antigens has been noted. Other changes in immune 
senescence include a decline in macrophage, neutrophil, and natural killer function with 
ageing 51. 
A more rapid and severe development of gingivitis as well as changes in inflammatory 
response induced by gingivitis in elderly patients have been reported 52. A greater presence 
of alpha 2-macroglobulin, IgG3, and B-lymphocytes in the crevicular fluid, and a reduction 
in polymorphonuclear leukocytes (PMN) have also been observed in the elderly 53.  
Periodontal ligament cells from the elderly showed an increase in the production of 
plasminogen activator (PA) 54, prostaglandin E2 (PGE2), interleukin-1┚ (IL-1┚) 6, 54 and 
interleukin-6 (IL-6) 55 when compared to younger cells.  
Lipopolysaccharide (LPS), responsible for bacterial cytotoxicity, is a component of the gram 
negative bacterial cell wall. It induces the activation of transcription factors in lymphocytes, 
promoting regions of DNA which activate genes that contribute to the adaptive response 
and secretion of pro-inflammatory cytokines 56.  
PA is a serine protease that acts in the activation of plasmatic plasminogen into plasmin and 
it is secreted by many cell types, including periodontal fibroblasts. The activity of PA and 
the expression of tissue plasminogen activator (tPA) mRNA in fibroblasts from the 
periodontal ligament in vitro submitted to mechanical tension were evaluated. The cells 
from elderly individuals presented greater activity of PA and greater expression of tPA 
mRNA when compared to those from young individuals 7. The action of PA is involved in 
physiological and pathological mechanisms of periodontium, including host-microbiota 
interaction, PMN migration, and proliferation and migration of both epithelial cells and 
fibroblasts 57. Analysis of PA distribution in the periodontium showed that, in healthy 
periodontium, PA is expressed in the superficial cells of the junctional epithelium. However, 
in patients with periodontitis, PA is expressed in all the epithelium lining of the periodontal 
pocket. The alteration in the pattern of PA distribution, according to periodontal status, 
suggests that PA is involved in the periodontal homeostasis 58.  
The levels of tPA and the plasminogen activator inhibitor-2 (PAI-2) are greater in gingival 
crevicular fluid of patients with periodontitis than in periodontally healthy patients 59. 
Patients with high levels of alveolar bone loss presented higher levels of tPA and PAI-2 than 
those with low levels of alveolar bone loss. A greater release of PA induced by ageing might 
affect the gingival fibroblasts and the periodontal ligament, and aggravate the inflammation 
process and the degradation of the extracellular matrix from periodontal tissues in the 
elderly 7, 53. 
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Fibroblasts from old mice (20 months) demonstrated a significant increase in the synthesis of 
PGE2 and IL-1┚ when compared to the fibroblasts from young mice (6 weeks) 54, 60. An 
increase in the production of PGE2 and Cox 2 mRNA stimulated by LPS and mechanical 
stress, respectively, was also observed in periodontal ligament cells from elderly donors 61, 62.  
PGE2 is produced by the metabolism of arachidonic acid through the cyclooxygenase (COX) 
pathway and has a recognized role in the inflammatory process, through vascular dilatation, 
increased in vascular permeability, and sensibilization of nociceptors to the stimulus of 
histamine and bradykinin. PGE2 may have an indirect effect on alveolar bone resorption by 
the sensibility of osteoclasts to the action of other cytokines involved in this process 63. In 
patients with periodontitis, high levels of PGE2 were observed to be related to the severity 
of periodontal disease and the increase in alveolar bone loss 64, 65. The greater production of 
PGE2 by old periodontal ligament cells might account for the greater rate of alveolar bone 
resorption in elderly patients 54, 66. 
In vitro studies have demonstrated an increase in the synthesis of IL-1┚ and in the 
expression of IL-1┚ mRNA in fibroblasts from human elderly donors and in fibroblasts of 
old mice, stimulated by mechanical stress 60, 66. Human gingival fibroblasts from elderly 
donors presented greater production of IL-6 by the stimulus of LPS from Campylobacter 
rectus when compared to young donors 55. IL-1┚ is the most active cytokine in the process of 
bone resorption, being 15 times more potent than IL-1┙ and 1000 times more potent than 
TNF-┚ 67. Patients with severe periodontal disease (periodontal pocket >6mm) presented 
with a rate of IL-1┚ twice times higher than that observed for patients with moderate 
(<4mm) and intermediate (4-6 mm) periodontal disease 67. In the same way, another study 
demonstrated that patients with periodontal bone loss had more IL-1┚ in the gingival fluid 
when compared to periodontal patients without bone loss (P<0.0001) 68. The levels of IL-1┙, 
IL-1┚, plaque accumulation, gingival fluid, and gingival inflammation in young adults (20-
22 years) and elderly (61-65 years) were compared with experimental periodontal disease. 
Levels of IL-1┚ in the gingival fluid were significantly higher in elderly, with a progressive 
increase until the 21st day of oral hygiene suspension, while levels of IL-1┙ were similar for 
both groups. In the elderly there was also an increase in plaque accumulation, gingival fluid, 
and clinical signs of inflammation 69.  
The pattern of IL-1┚ and IL-6 secretion in periodontal disease in menopausal patients was 
analyzed 34. The results demonstrated that menopausal patients that were not in hormone 
reposition therapy presented higher rates of IL-1┚ (p < 0.0004) and IL-6 (p>0.05) than 
patients under hormonal treatment. IL-6 has an important role in the osseous lyses in 
periodontitis. It acts stimulating the growth and proliferation of osteoclast precursors and 
there is evidence that it is an extracellular messenger signaling osteoblast resorption for the 
osteoclast 55. A greater concentration of IL-1┚ e IL-8 in patients with estrogen deficiency 
compared to untreated patients without estrogen deficiency was also observed 70. The 
hypothesis that the greater liberation of IL-1┚ by older periodontal ligament cells may 
represent an important factor for the greater rate of alveolar bone resorption in elderly 
patients has been proposed 54, 60, 66.  
Periodontal ligament fibroblasts also express osteoblastic phenotypes, such as the 
production of bone-like matrix proteins, high alkaline phosphatase activity, and the 
formation of calcified nodules 71. In addition, human periodontal ligament cells express and 
secrete osteoprotegerin (OPG) 72 and receptor activator of NF-kappa B ligand (RANKL) such 
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RANKL, a member of tumor necrosis factor (TNF) ligand family, is expressed on 
osteoblast/stromal cell membranes. This ligand binds to the receptor activator of NF-kappa 
B (RANK), which is a receptor on the membrane of osteoclasts and mononuclear pre-
osteoclasts, and induces osteoclast differentiation and activity 74, 75. In contrast, OPG is 
known to inhibit osteoclast differentiation and activity by interrupting the interaction 
between RANKL and its receptor, RANK, by binding to RANKL as a decoy receptor with 
higher affinity than RANK 76. 
RANKL expressed on gingival or synovial fibroblasts may direct macrophages present in 
connective tissue and monocytes recruited from blood to differentiate into osteoclasts, 
which leads to bone destruction in periodontitis or arthritis. RANKL is expressed also on 
activated T-cells 73, 75. RANKL promoted the survival of mature dendritic cells and enhances 
the ability of these cells to stimulate T-cell proliferation in a mixed leukocyte reaction. In 
addition, RANKL induced the production of proinflammatory cytokines (IL-1 and IL-6) and 
cytokines that direct differentiation of T- cells, such as IL-12 and IL-15 from dendritic cells 77. 
In periodontitis, LPS, which is a combination of lipid and polysaccharide, is a component of 
the outer membrane of gram-negative bacteria 56. It has been reported that toll-like-receptor-
4 (TLR4), a protein that in humans is encoded by the TLR4 gene and it detect 
lipopolysaccharide from Gram-negative bacteria, is essential for the response to LPS 78. 
Human periodontal ligament fibroblasts express TLR4, suggesting that LPS directly acts on 
these cells. LPS interacts with endotoxin and CD14 (endotoxin receptor) to present LPS to 
TLR-4, which activates inflammatory gene expression through NF-kappa-B. CD14 is a 
critical receptor for LPS because monoclonal antibodies directed against CD14 can inhibit 
the biological effects induced both in vitro and in vivo by LPS 79. 
LPS induces inflammatory cytokines, such as interleukin-1 beta (IL-1┚) and tumor necrosis 
factor-alpha (TNF-┙), in macrophages and neutrophilic leukocytes that infiltrate areas 
infected with bacteria, and in periodontal ligament fibroblasts 80. These cytokines are 
thought to play an important role in the pathogenesis of periodontitis because they cause 
inflammation and destruction of periodontal tissue and resorption of alveolar bone by 
various biological mechanisms. IL-1 and TNF-a induce bone resorption by acting both 
directly and indirectly on osteoclasts 81.  
The effects of LPS on OPG and RANKL expression in human periodontal ligament 
fibroblasts (HPLF) were reported. These suggest that LPS stimulates both OPG and RANKL 
expression in HPLF by up-regulating IL-1┚ and TNF-┙ 82. 
All of these studies related to the dynamics of the inflammatory process allow a better 
understanding of the interaction of immunosenescence on cells periodontal. However, 
continuous research on this subject should be held. 
5. Ageing as a risk factor for periodontal disease 
The age-related changes in the periodontal tissues show that increasing age could potentially 
be a risk factor for periodontal disease 83. Some moderate loss of periodontal attachment and 
alveolar bone is associated with age, but age alone in a healthy adult does not lead to a critical 
loss of periodontal support. Although moderate loss of alveolar bone and periodontal 
attachment is common in the elderly, severe periodontitis is not a natural consequence of 
ageing 3, 83. Clinical attachment level and bone loss are irreversible measures of prior disease 
experience. Cross-sectional studies measuring disease experience demonstrated more 
attachment loss and alveolar bone loss among older age groups than other groups 3.  
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Longitudinal studies addressing potential relationships between age and attachment loss or 
bone loss showed statistically significant relationships between age and incidence of 
periodontal disease 84-86. However, this age-associated increase in risk may not be linear, 
since some studies show no significant differences within age groups above 65 years 87-91.  
The main issue related of this fact is the magnitude of any increase in risk. Studies that 
demonstrate statistically significant associations do not necessarily indicated that these will 
lead to severe clinical outcome for older adults 92. A 28-year follow-up study reported an 
odds ratio of 10.4 for people aged 36-50 years compared with people aged 5-15 years. While 
this result is comparable in magnitude with other clinically important risk factors (smoking 
odds ratio in the same study was 14), it corresponds to a mean increase in clinical 
attachment level of only 1.34 mm over 28 years 85.  
This level of increased risk probably is not sufficient, alone, to cause tooth loss. Consequently, 
periodontal disease may be considered as time-associated, and ageing itself appears to be 
responsible for some attachment and bone loss, it is of a magnitude that is unlikely to have a 
clinical significance 83, 92. This fact is influenced by multiple factors that have been found to be 
associated with the prevalence and incidence of the periodontal disease 88.  
6. Clinical Implications on ageing 
Periodontal disease is not thought to be the major cause of tooth loss among adults, the loss 
of teeth in epidemiological studies usually induce an underestimate of periodontal disease 
incidence, since attachment loss tends to be greater in teeth that are extracted (whether or 
not the extraction is due to periodontal disease), and such teeth cannot be measured in 
follow-up studies 92. 
Although longitudinal studies showed moderate levels of attachment loss in a high 
percentage of middle-aged and elderly subjects, severe loss is confined to a minority. 
Approximately one-fifth of older patients have experienced more generalized severe loss. 
The rate is higher in the oldest subjects 92. The habitual observation in elderly populations is 
some loss of periodontal attachment and alveolar bone, but age alone in a healthy adult does 
not lead to a critical loss of periodontal support 3.  
The most important clinical conclusion to draw from the longitudinal studies concerning the 
effects of aging is that increased age poses some increased risk for periodontal loss, but the 
amount of loss due to age alone is probably consistent with “successful aging” rather than 
accelerated pathological processes 92. Really, it is probably appropriate to view the aging-
periodontitis association as a rationale for redefining appropriate endpoints of periodontal 
therapy, such that the objective of treatment is to maintain a functioning dentition rather 
than a perfect level of periodontal attachment. Models for decision making regarding 
periodontal treatment needs in elderly have been proposed. Age-related thresholds could be 
used to decide on appropriate levels of therapy 92, 93. 
Recognition of the dental needs of this special category of the population compels us to bear 
the responsibility of treating them now and in the future. One of the major criteria of 
successful ageing is to maintain a natural, healthy, functional dentition throughout life, 
including all the social and biological benefits, such as aesthetics and comfort, and the 
ability to chew, taste and speak. However, the oral health of elderly people is far from 
optimal. The demand for treatment is much lower than the need. In the future the elderly 
will retain their natural dentition and more teeth per individual will be present 94. This fact 
can result in an increase in periodontal disease expectancy among the dentate elderly 2. 
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Certainly, in a short time, the trends for oral health care will be change. The new elderly 
populations will be more critical and more demanding for oral health care services than 
current elderly population. The dental profession must be aware of these trends which 
should be reflected in undergraduate and postgraduate dental education 94. In worldwide, 
some countries recognized the Geriatric Dentistry as a new specialty into the dentistry 95 or 
included specific dental programs for elderly treatment and research 96. If as an specific 
specialty or developed by a established specialty, such as the Periodontics, periodontal care 
services for elderly people must show proficient dental professionals, including knowledge 
about the ageing interactions on periodontal treatment. 
7. Conclusions 
In conclusion, ageing alone leads to no critical loss of the periodontal attachment in the 
healthy elderly. The effects of ageing human on periodontal tissues were based on 
biomolecular changes of the cells of periodontium that exacerbate bone loss in elderly 
patients with periodontitis 83.  
These effects may be associated with: 1) alterations in differentiation and proliferation of 
osteoblasts and osteoclasts; 2) an increase in periodontal cell response to the oral microbiota 
and mechanical stress leading to the secretion of cytokines involved in bone loss; and 3) 
systemic endocrine alterations in the elderly 83.  
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